1. Home
  2. SUNS vs SLGL Comparison

SUNS vs SLGL Comparison

Compare SUNS & SLGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunrise Realty Trust Inc.

SUNS

Sunrise Realty Trust Inc.

HOLD

Current Price

$9.23

Market Cap

124.1M

Sector

Real Estate

ML Signal

HOLD

Logo Sol-Gel Technologies Ltd.

SLGL

Sol-Gel Technologies Ltd.

HOLD

Current Price

$68.81

Market Cap

117.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SUNS
SLGL
Founded
2023
1997
Country
United States
Israel
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
124.1M
117.8M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
SUNS
SLGL
Price
$9.23
$68.81
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$13.00
$50.00
AVG Volume (30 Days)
138.6K
21.8K
Earning Date
03-05-2026
11-20-2025
Dividend Yield
12.97%
N/A
EPS Growth
1112.46
N/A
EPS
1.09
N/A
Revenue
$19,384,703.00
$18,970,000.00
Revenue This Year
$175.51
$122.71
Revenue Next Year
$63.46
N/A
P/E Ratio
$8.48
N/A
Revenue Growth
2540.16
62.04
52 Week Low
$7.80
$4.02
52 Week High
$14.29
$71.99

Technical Indicators

Market Signals
Indicator
SUNS
SLGL
Relative Strength Index (RSI) 41.69 81.92
Support Level $9.05 $60.20
Resistance Level $9.39 $71.99
Average True Range (ATR) 0.26 4.55
MACD -0.04 2.18
Stochastic Oscillator 27.92 85.92

Price Performance

Historical Comparison
SUNS
SLGL

About SUNS Sunrise Realty Trust Inc.

Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

Share on Social Networks: